Literature DB >> 22534529

Vaccines: The take-home lesson.

Sarah DeWeerdt.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22534529     DOI: 10.1038/484S24a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; Solange Solmeheim Soulanoudjingar; José Francisco Fernandes; Béatrice Peggy Abossolo; Cornelia Conzelmann; Barbara Gaelle Nfono Ondo Methogo; Yannick Doucka; Arnaud Flamen; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Arlindo Nhamuave; Diana Quelhas; Quique Bassat; Sofia Mandjate; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Omar Juma; Mwanajaa Shomari; Kafuruki Shubis; Francisca Machera; Ali Said Hamad; Rose Minja; Ali Mtoro; Alma Sykes; Saumu Ahmed; Alwisa Martin Urassa; Ali Mohammed Ali; Grace Mwangoka; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Marc Christian Tahita; William Kaboré; Sayouba Ouédraogo; Yara Sandrine; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Chris Odero; Martina Oneko; Kephas Otieno; Norbert Awino; Jackton Omoto; John Williamson; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Otsyula Nekoye; Stacey Gondi; Allan Otieno; Bernhards Ogutu; Ruth Wasuna; Victorine Owira; David Jones; Agnes Akoth Onyango; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Jesse Gitaka; Charity Maingi; Trudie Lang; Ally Olotu; Benjamin Tsofa; Philip Bejon; Norbert Peshu; Kevin Marsh; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; Samuel Ayamba; Kingsley Kayan; Ruth Owusu-Ofori; David Dosoo; Isaac Asante; George Adjei; George Adjei; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Hassan Kilavo; Coline Mahende; Edwin Liheluka; Martha Lemnge; Thor Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Alex Agyekum; Larko Owusu; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Ruthendo Nkomo; Albans Msika; Allan Jumbe; Nelecy Chome; Dalitso Nyakuipa; Joseph Chintedza; W Ripley Ballou; Myriam Bruls; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Johan Vekemans; Terrell Carter; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2011-10-18       Impact factor: 91.245

2.  Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.

Authors:  Meta Roestenberg; Anne C Teirlinck; Matthew B B McCall; Karina Teelen; Krystelle Nganou Makamdop; Jorien Wiersma; Theo Arens; Pieter Beckers; GeertJan van Gemert; Marga van de Vegte-Bolmer; André J A M van der Ven; Adrian J F Luty; Cornelus C Hermsen; Robert W Sauerwein
Journal:  Lancet       Date:  2011-04-22       Impact factor: 79.321

3.  Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

Authors:  J E Epstein; K Tewari; K E Lyke; B K L Sim; P F Billingsley; M B Laurens; A Gunasekera; S Chakravarty; E R James; M Sedegah; A Richman; S Velmurugan; S Reyes; M Li; K Tucker; A Ahumada; A J Ruben; T Li; R Stafford; A G Eappen; C Tamminga; J W Bennett; C F Ockenhouse; J R Murphy; J Komisar; N Thomas; M Loyevsky; A Birkett; C V Plowe; C Loucq; R Edelman; T L Richie; R A Seder; S L Hoffman
Journal:  Science       Date:  2011-09-08       Impact factor: 47.728

Review 4.  Flipping the paradigm on malaria transmission-blocking vaccines.

Authors:  Rhoel R Dinglasan; Marcelo Jacobs-Lorena
Journal:  Trends Parasitol       Date:  2008-07-01

5.  Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

Authors:  Yimin Wu; Ruth D Ellis; Donna Shaffer; Erica Fontes; Elissa M Malkin; Siddhartha Mahanty; Michael P Fay; David Narum; Kelly Rausch; Aaron P Miles; Joan Aebig; Andrew Orcutt; Olga Muratova; Guanhong Song; Lynn Lambert; Daming Zhu; Kazutoyo Miura; Carole Long; Allan Saul; Louis H Miller; Anna P Durbin
Journal:  PLoS One       Date:  2008-07-09       Impact factor: 3.240

  5 in total
  5 in total

1.  Synergistic and antagonistic interactions between bednets and vaccines in the control of malaria.

Authors:  Yael Artzy-Randrup; Andrew P Dobson; Mercedes Pascual
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

Review 2.  Recent advances in malaria drug discovery.

Authors:  Marco A Biamonte; Jutta Wanner; Karine G Le Roch
Journal:  Bioorg Med Chem Lett       Date:  2013-03-27       Impact factor: 2.823

3.  Plasmodium falciparum ookinete expression of plasmepsin VII and plasmepsin X.

Authors:  Fengwu Li; Viengngeun Bounkeua; Kenneth Pettersen; Joseph M Vinetz
Journal:  Malar J       Date:  2016-02-24       Impact factor: 2.979

4.  Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.

Authors:  Sara E White; Steven A Harvey; Graciela Meza; Alejandro Llanos; Mitchel Guzman; Dionicia Gamboa; Joseph M Vinetz
Journal:  Malar J       Date:  2018-04-27       Impact factor: 2.979

Review 5.  Arbovirosis and potential transmission blocking vaccines.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Tonya M Colpitts
Journal:  Parasit Vectors       Date:  2016-09-23       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.